Search

Search Results

• 

  05 | Revisiting cancer risk associated with the MITF p.e318k variant beyond melanoma Debora Tonello¹, Beatrice Zennaro¹, Stefania Pellegrini¹, Monica Quaggio², Luisa Piccin³, Alessio Fabozzi⁴, Luigi Dall’Olmo^2|5, Saveria Tropea⁵, Maria Chiara Scaini¹, Chiara Menin¹ | ¹Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova; ²Department of Surgery, Oncology and Gastroenterology, Section of Immunology and Oncology, AIDS Reference Center, University of Padova, Padova; ³Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova; ⁴Oncology Unit 3, Veneto Institute of Oncology - IOV-IRCCS, Padua; ⁵Soft-Tissue, Peritoneum, and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10747

  305
• 

  31 | Effectiveness and safety of adjuvant combo-targeted and immunotherapy in melanoma patients Valentina Salizzato¹, Luisa Piccin¹, Alessio Fabozzi², Paolo Del Fiore³, Francesco Cavallin⁴, Chiara Cacco^1|5, Simone Mocellin^3|5, Marcodomenico Mazza³, Valentina Guarneri^1|5, Jacopo Pigozzo¹ | ¹Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova; ²Medical Oncology 3, Veneto Institute of Oncology IOV-IRCCS, Padova; ³Soft-Tissue, Peritoneum and Melanoma Surgical Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova; ⁴Independent Statistician, Solagna; ⁵Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10773

  246